SAUDI PHARMACEUTICAL JOURNAL, cilt.23, sa.6, ss.720-722, 2015 (SCI-Expanded, Scopus)
Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.